Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMYX0BL)

Drug Name
MYRISTIC ACID Drug Info
Synonyms
Tetradecanoic acid; MYRISTIC ACID; 544-63-8; n-Tetradecanoic acid; n-Tetradecoic acid; Crodacid; n-Tetradecan-1-oic acid; 1-Tridecanecarboxylic acid; Univol U 316S; Hydrofol acid 1495; Emery 655; Myristinsaeure; Myristate; tetradecoic acid; Hystrene 9014; Neo-fat 14; Myristic acid (natural); C14 fatty acid; Myristic acid, pure; n-Myristic acid; Tetradecanoate; acide tetradecanoique; NSC 5028; FEMA No. 2764; CCRIS 4724; CH3-[CH2]12-COOH; HSDB 5686; UNII-0I3V7S25AW; Philacid 1400; CHEBI:28875; AI3-15381; Prifac 2942; C14:0; EINECS 208-875-2
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
11005
ChEBI ID
CHEBI:28875
CAS Number
CAS 544-63-8
TTD Drug ID
DMYX0BL

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
DOT
Drug Status:
Investigative Drug(s)
Approved Drug(s)
Clinical Trial Drug(s)
Discontinued Drug(s)
Preclinical Drug(s)
Download the Complete Related Drug List
Drug(s) Targeting Hepatocyte nuclear factor 4-alpha (HNF4A)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Lauric Acid DM9C8KQ Discovery agent N.A. Investigative [7]
BI6015 DMRXK5G Discovery agent N.A. Investigative [8]
Drug(s) Targeting Calmodulin (CALM)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Halofantrine DMOMK1V Malaria 1F40-1F45 Approved [9]
Trifluoperazine DMKBYWI Anxiety Approved [10]
Aprindine DMBXWU8 Cardiac arrhythmias BC9Z Approved [11]
Acetate Ion DMD08RH Discovery agent N.A. Investigative [7]
2-Methyl-2,4-Pentanediol DMD45CU Discovery agent N.A. Investigative [7]
Cacodylate Ion DMK4XLD Discovery agent N.A. Investigative [7]
2-Methyl-2-Propanol DMHM5GJ Discovery agent N.A. Investigative [7]
N-Trimethyllysine DMZQXLS Discovery agent N.A. Investigative [7]
Calmidazolium DM5ZTJL Huntington disease 8A01.10 Investigative [12]
⏷ Show the Full List of 9 Drug(s)
Drug(s) Targeting Lymphocyte antigen 96 (LY96)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Lauric Acid DM9C8KQ Discovery agent N.A. Investigative [7]
3-Hydroxy-Myristic Acid DMFJLWO Discovery agent N.A. Investigative [7]
Drug(s) Targeting Tyrosine-protein kinase ABL1 (ABL)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ponatinib DMYGJQO Acute lymphoblastic leukaemia 2A85 Approved [13]
Bosutinib DMTI8YE Blast phase chronic myelogenous leukemia, BCR-ABL1 positive Approved [14]
SKI-758 DMQ8E9R Ischemia 8B10-8B11 Approved [15]
Adenosine triphosphate DM79F6G Malnutrition 5B50-5B71 Approved [16]
Saracatinib DMBLHGP Hematologic tumour 2B33.Y Phase 2 [17]
Flumatinib DM0G5O6 Chronic myelogenous leukaemia 2A20.0 Phase 2 [18]
DCC-2036 DMJKFNU Chronic myeloid leukaemia 2A20 Phase 1/2 [19]
ISIS-CRP DMQDUG4 Cardiovascular disease BA00-BE2Z Phase 1 [20]
KW-2449 DMFO7RP Acute myeloid leukaemia 2A60 Phase 1 [21]
IkT-148009 DMMJ9HY Parkinson disease 8A00.0 Phase 1 [22]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Targeting FK506-binding protein 1A (FKBP1A)
Drug Name Drug ID Indication ICD 11 Highest Status REF
GPI-1485 DM64ZYM Parkinson disease 8A00.0 Phase 2 [23]
SDZ-281-240 DMPZ67G Pruritus EC90 Phase 2 [24]
AP1903 DM2LU8M Transplant rejection NE84 Phase 1/2 [25]
Gpi-1046 DMD5WK4 Parkinson disease 8A00.0 Terminated [2]
Heptyl-Beta-D-Glucopyranoside DMPQBN0 Discovery agent N.A. Investigative [26]
4-Hydroxy-2-Butanone DM7BQ65 Discovery agent N.A. Investigative [7]
L-709,587 DM9KCYQ Discovery agent N.A. Investigative [7]
Methyl Methylsulfinylmethyl Sulfide DMOCXLW Discovery agent N.A. Investigative [7]
Rapamycin Immunosuppressant Drug DM678IB Discovery agent N.A. Investigative [7]
FKB-001 DM9K834 Discovery agent N.A. Investigative [7]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Targeting Virus Genome polyprotein (Viru POL)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Lauric Acid DM9C8KQ Discovery agent N.A. Investigative [7]
Drug(s) Targeting Toll-like receptor 4 (TLR4)
Drug Name Drug ID Indication ICD 11 Highest Status REF
MPL-containing Pollinex allergy desensitization vaccine DMXSDJU Allergy 4A80-4A85 Preregistration [27]
Cadi-05 DMPTCYB Prostate cancer 2C82.0 Phase 3 [28]
Resatorvid DMFMWYC Sepsis 1G40-1G41 Phase 3 [29]
ERITORAN DMKQZ0L Sepsis 1G40-1G41 Phase 3 [30]
G100 DMKHNXA Non-hodgkin lymphoma 2B33.5 Phase 2 [31]
OM-174 DM2THBX Solid tumour/cancer 2A00-2F9Z Phase 1 [32]
NI-0101 DM31FOP Autoimmune diabetes 5A10 Phase 1 [33]
GSK1795091 DMC6QE4 Solid tumour/cancer 2A00-2F9Z Phase 1 [31]
CRX-675 DMHDSYF Hepatitis virus infection 1E50-1E51 Phase 1 [33]
CS-4771 DMVDLT4 Sepsis 1G40-1G41 Discontinued in Phase 1 [34]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Targeting Human immunodeficiency virus Negative factor (HIV nef)
Drug Name Drug ID Indication ICD 11 Highest Status REF
F4co vaccine DM6UQNW Human immunodeficiency virus infection 1C62 Phase 2 [35]
LIPO-5 DMWY0V1 Human immunodeficiency virus infection 1C62 Phase 2 [36]
Ad35-GRIN DM4L28K Human immunodeficiency virus infection 1C62 Phase 1/2 [37]
Ad35-GRIN/ENV DMG82ZA Human immunodeficiency virus infection 1C62 Phase 1 [37]
GSK-732461 DMJ0ZB6 Human immunodeficiency virus infection 1C62 Discontinued in Phase 2 [38]
Drug(s) Targeting Pseudomonas UDP-3-O-acyl-GlcNAc deacetylase (Pseudo lpxC)
Drug Name Drug ID Indication ICD 11 Highest Status REF
LpxC-1 DMV1A25 Acinetobacter baumannii infection CA40.0Y Preclinical [39]
RC-01 DM4FNWO Gram-negative bacterial infection 1B74-1G40 Terminated [40]
Cacodylate Ion DMK4XLD Discovery agent N.A. Investigative [7]
Palmitoleic Acid DM4W5X8 Discovery agent N.A. Investigative [7]
3-(heptyloxy)benzoic acid DMQZU9G Discovery agent N.A. Investigative [2]
BB-78484 DMFBN9O Discovery agent N.A. Investigative [41]
BB-78485 DMJKA3F Discovery agent N.A. Investigative [41]
Tu-514 DMUR0TF Discovery agent N.A. Investigative [7]
⏷ Show the Full List of 8 Drug(s)
Drug(s) Affected By Peroxisome proliferator-activated receptor alpha (PPARA)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [42]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [43]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [44]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [45]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [46]
Prasterone DM67VKL Chronic obstructive pulmonary disease CA22 Approved [47]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [48]
Testosterone DM7HUNW Hot flushes GA30 Approved [49]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [50]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [51]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PPARGC1A)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [52]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [53]
Fructose DM43AN2 Vomiting MD90 Approved [54]
Glucosamine DM4ZLFD Osteoarthritis FA00-FA05 Approved [55]
Isoniazid DM5JVS3 Latent tuberculosis infection Approved [56]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [57]
Ketotifen DM74XKS Allergic conjunctivitis 9A60.02 Approved [58]
Riboflavin DM8YMWE Acne vulgaris ED80 Approved [6]
Leflunomide DMR8ONJ Arthritis FA20 Approved [59]
Glutathione DMAHMT9 Human immunodeficiency virus infection 1C62 Approved [6]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Cytochrome P450 4Z1 (CYP4Z1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [60]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [60]
20-HETE DM5BAJ9 Discovery agent N.A. Investigative [4]
Lauric Acid DM9C8KQ Discovery agent N.A. Investigative [4]
Drug(s) Affected By Albumin (ALB)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [61]
Sulfamethoxazole DMB08GE Acute otitis media AB00 Approved [62]
Tolbutamide DM02AWV Advanced cancer 2A00-2F9Z Approved [63]
Diazepam DM08E9O Alcohol withdrawal Approved [64]
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [65]
Methimazole DM25FL8 Hyperthyroidism 5A02 Approved [66]
Imipramine DM2NUH3 Depression 6A70-6A7Z Approved [67]
Colchicine DM2POTE Acute gout flare FA25.0 Approved [68]
Methotrexate DM2TEOL Anterior urethra cancer Approved [69]
Quercetin DM3NC4M Obesity 5B81 Approved [70]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas
Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Calmodulin (CALM) TTV3NH6 CALM1_HUMAN; CALM2_HUMAN; CALM3_HUMAN Inhibitor [2]
FK506-binding protein 1A (FKBP1A) TTMW94E FKB1A_HUMAN Inhibitor [2]
Hepatocyte nuclear factor 4-alpha (HNF4A) TT2F3CD HNF4A_HUMAN Inhibitor [2]
Human immunodeficiency virus Negative factor (HIV nef) TT4NXYM NEF_HV1A2 Inhibitor [2]
Lymphocyte antigen 96 (LY96) TT8S9AV LY96_HUMAN Inhibitor [2]
Pseudomonas UDP-3-O-acyl-GlcNAc deacetylase (Pseudo lpxC) TT0OFWN LPXC_PSEAE Inhibitor [2]
Recoverin (RCVRN) TTDQTEY RECO_HUMAN Inhibitor [2]
Toll-like receptor 4 (TLR4) TTISGCA TLR4_HUMAN Inhibitor [2]
Tyrosine-protein kinase ABL1 (ABL) TT3PJMV ABL1_HUMAN Inhibitor [2]
Virus Genome polyprotein (Viru POL) TTVBE0F POLG_HRV1A Inhibitor [2]

Drug Off-Target (DOT)
DOT Name DOT ID UniProt ID Interaction REF
Albumin (ALB) OTVMM513 ALBU_HUMAN Drug Response [3]
Cytochrome P450 4Z1 (CYP4Z1) OTKRGJBG CP4Z1_HUMAN Regulation of Drug Effects [4]
Peroxisome proliferator-activated receptor alpha (PPARA) OTK095PP PPARA_HUMAN Protein Interaction/Cellular Processes [5]
Peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PPARGC1A) OTHCDQ22 PRGC1_HUMAN Gene/Protein Processing [6]

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2806).
2 The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
3 Fatty acids binding to human serum albumin: Changes of reactivity and glycation level of Cysteine-34 free thiol group with methylglyoxal. Chem Biol Interact. 2014 Dec 5;224:42-50. doi: 10.1016/j.cbi.2014.10.008. Epub 2014 Oct 17.
4 Increased expression of CYP4Z1 promotes tumor angiogenesis and growth in human breast cancer. Toxicol Appl Pharmacol. 2012 Oct 1;264(1):73-83. doi: 10.1016/j.taap.2012.07.019. Epub 2012 Jul 25.
5 Evidence for direct binding of fatty acids and eicosanoids to human peroxisome proliferators-activated receptor alpha. Biochem Biophys Res Commun. 1999 Jul 14;260(3):609-13. doi: 10.1006/bbrc.1999.0951.
6 A cardiac-specific robotized cellular assay identified families of human ligands as inducers of PGC-1 expression and mitochondrial biogenesis. PLoS One. 2012;7(10):e46753. doi: 10.1371/journal.pone.0046753. Epub 2012 Oct 3.
7 How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6.
8 HNF4alpha antagonists discovered by a high-throughput screen for modulators of the human insulin promoter. Chem Biol. 2012 Jul 27;19(7):806-18.
9 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services.
10 Inhibitory effect of jujuboside A on glutamate-mediated excitatory signal pathway in hippocampus. Planta Med. 2003 Aug;69(8):692-5.
11 Aprindine inhibits calmodulin-stimulated phosphodiesterase and Ca-ATPase activities. J Cardiovasc Pharmacol. 1983 Jan-Feb;5(1):151-6.
12 Calmidazolium evokes high calcium fluctuations in Plasmodium falciparum. Cell Signal. 2016 Mar;28(3):125-135.
13 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
14 A comparison of physicochemical property profiles of marketed oral drugs and orally bioavailable anti-cancer protein kinase inhibitors in clinical development. Curr Top Med Chem. 2007;7(14):1408-22.
15 Synthesis and Src kinase inhibitory activity of a series of 4-[(2,4-dichloro-5-methoxyphenyl)amino]-7-furyl-3-quinolinecarbonitriles. J Med Chem. 2006 Dec 28;49(26):7868-76.
16 Targeted chronic myeloid leukemia therapy: Seeking a cure. Am J Health Syst Pharm. 2007 Dec 15;64(24 Suppl 15):S9-15.
17 Novel dual Src/Abl inhibitors for hematologic and solid malignancies.Expert Opin Investig Drugs.2010 Aug;19(8):931-45.
18 Flumatinib, a selective inhibitor of BCR-ABL/PDGFR/KIT, effectively overcomes drug resistance of certain KIT mutants. Cancer Sci. 2014 Jan;105(1):117-25.
19 Company report (Deciphera Pharmaceuticals: Tumor-Targeted Programs and Indications)
20 Structure-based optimization of pyrazolo[3,4-d]pyrimidines as Abl inhibitors and antiproliferative agents toward human leukemia cell lines. J Med Chem. 2008 Mar 13;51(5):1252-9.
21 KW-2449, a novel multikinase inhibitor, suppresses the growth of leukemia cells with FLT3 mutations or T315I-mutated BCR/ABL translocation. Blood. 2009 Aug 20;114(8):1607-17.
22 The c-Abl inhibitor IkT-148009 suppresses neurodegeneration in mouse models of heritable and sporadic Parkinson's disease. Sci Transl Med. 2023 Jan 18;15(679):eabp9352.
23 Drugs used to treat Parkinson's disease, present status and future directions. CNS Neurol Disord Drug Targets. 2008 Oct;7(4):321-42.
24 Clearing of psoriasis by a novel immunosuppressive macrolide. J Invest Dermatol. 1996 Apr;106(4):701-10.
25 Using gene transfer to circumvent off-target effects. Gene Ther. 2008 May;15(10):759-64.
26 DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Nucleic Acids Res. 2011 Jan;39(Database issue):D1035-41.
27 Allergy Therapeutics PLC. News Announcement. Allergy Therapeutics. Clinical Trials. Allergy Therapeutics PLC. 11 October 2006.
28 Trial Watch: Experimental Toll-like receptor agonists for cancer therapy. Oncoimmunology. 2012 August 1; 1(5): 699-716.
29 Clinical pipeline report, company report or official report of Takeda (2009).
30 Small molecule modulators of toll-like receptors. J Med Chem. 2008 Nov 13;51(21):6621-6.
31 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
32 Phase I study of OM-174, a lipid A analogue, with assessment of immunological response, in patients with refractory solid tumors. BMC Cancer. 2013 Apr 2;13:172.
33 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 1754).
34 Eritoran insight for influenza treatment. SciBX 6(19); doi:10.1038/scibx.2013.453. May 16 2013
35 EP patent application no. 2621528, Vaccine.
36 HIV specific responses induced in nonhuman primates with ANRS HIV-Lipo-5 vaccine combined with rMVA-HIV prime or boost immunizations. Vaccine. 2015 May 11;33(20):2354-9.
37 A phase I double blind, placebo-controlled, randomized study of a multigenic HIV-1 adenovirus subtype 35 vector vaccine in healthy uninfected adults. PLoS One. 2012;7(8):e41936.
38 Preventive technologies, research toward a cure, and immune-based and gene therapies. HIV Treatment Bulletin. 30 June 2013.
39 Different drugs for bad bugs: antivirulence strategies in the age of antibiotic resistance. Nat Rev Drug Discov. 2017 Jul;16(7):457-471.
40 The global preclinical antibacterial pipeline. Nat Rev Microbiol. 2020 May;18(5):275-285.
41 Antibacterial activities and characterization of novel inhibitors of LpxC. Antimicrob Agents Chemother. 2002 Jun;46(6):1793-9.
42 The contribution of methotrexate exposure and host factors on transcriptional variance in human liver. Toxicol Sci. 2007 Jun;97(2):582-94.
43 The ligands/activators for peroxisome proliferator-activated receptor alpha (PPARalpha) and PPARgamma increase Cu2+,Zn2+-superoxide dismutase and decrease p22phox message expressions in primary endothelial cells. Metabolism. 2001 Jan;50(1):3-11.
44 Development of a neural teratogenicity test based on human embryonic stem cells: response to retinoic acid exposure. Toxicol Sci. 2011 Dec;124(2):370-7.
45 Arsenic trioxide promotes senescence and regulates the balance of adipogenic and osteogenic differentiation in human mesenchymal stem cells. Acta Biochim Biophys Sin (Shanghai). 2011 Mar;43(3):204-9. doi: 10.1093/abbs/gmq130. Epub 2011 Jan 21.
46 Aspirin inhibits MMP-9 mRNA expression and release via the PPARalpha/gamma and COX-2/mPGES-1-mediated pathways in macrophages derived from THP-1 cells. Biomed Pharmacother. 2010 Feb;64(2):118-23. doi: 10.1016/j.biopha.2009.04.033. Epub 2009 Oct 17.
47 Modulation of receptor phosphorylation contributes to activation of peroxisome proliferator activated receptor alpha by dehydroepiandrosterone and other peroxisome proliferators. Mol Pharmacol. 2008 Mar;73(3):968-76. doi: 10.1124/mol.107.036780. Epub 2007 Dec 13.
48 (9)-THC modulation of fatty acid 2-hydroxylase (FA2H) gene expression: possible involvement of induced levels of PPARalpha in MDA-MB-231 breast cancer cells. Toxicology. 2014 Dec 4;326:18-24.
49 Effects of 1alpha,25 dihydroxyvitamin D3 and testosterone on miRNA and mRNA expression in LNCaP cells. Mol Cancer. 2011 May 18;10:58.
50 Cross-talk between vitamin D receptor (VDR)- and peroxisome proliferator-activated receptor (PPAR)-signaling in melanoma cells. Anticancer Res. 2009 Sep;29(9):3647-58.
51 Comparison of HepG2 and HepaRG by whole-genome gene expression analysis for the purpose of chemical hazard identification. Toxicol Sci. 2010 May;115(1):66-79.
52 Comparison of phenotypic and transcriptomic effects of false-positive genotoxins, true genotoxins and non-genotoxins using HepG2 cells. Mutagenesis. 2011 Sep;26(5):593-604.
53 Troglitazone induces cytotoxicity in part by promoting the degradation of peroxisome proliferator-activated receptor co-activator-1 protein. Br J Pharmacol. 2010 Oct;161(4):771-81. doi: 10.1111/j.1476-5381.2010.00900.x.
54 Effects of four-week high-fructose diet on gene expression in skeletal muscle of healthy men. Diabetes Metab. 2008 Feb;34(1):82-5. doi: 10.1016/j.diabet.2007.08.004. Epub 2007 Dec 11.
55 Glucosamine-induced endoplasmic reticulum stress affects GLUT4 expression via activating transcription factor 6 in rat and human skeletal muscle cells. Diabetologia. 2010 May;53(5):955-65. doi: 10.1007/s00125-010-1676-1. Epub 2010 Feb 18.
56 AMPK activator acadesine fails to alleviate isoniazid-caused mitochondrial instability in HepG2 cells. J Appl Toxicol. 2017 Oct;37(10):1219-1224. doi: 10.1002/jat.3483. Epub 2017 May 29.
57 Essential role of cell cycle regulatory genes p21 and p27 expression in inhibition of breast cancer cells by arsenic trioxide. Med Oncol. 2011 Dec;28(4):1225-54.
58 Advantageous use of HepaRG cells for the screening and mechanistic study of drug-induced steatosis. Toxicol Appl Pharmacol. 2016 Jul 1;302:1-9. doi: 10.1016/j.taap.2016.04.007. Epub 2016 Apr 16.
59 Endoplasmic reticulum stress and MAPK signaling pathway activation underlie leflunomide-induced toxicity in HepG2 Cells. Toxicology. 2017 Dec 1;392:11-21.
60 Conditional regulation of the human CYP4X1 and CYP4Z1 genes. Arch Biochem Biophys. 2005 Apr 15;436(2):377-85. doi: 10.1016/j.abb.2005.02.022.
61 Gene expression analysis of precision-cut human liver slices indicates stable expression of ADME-Tox related genes. Toxicol Appl Pharmacol. 2011 May 15;253(1):57-69.
62 ADReCS-Target: target profiles for aiding drug safety research and application. Nucleic Acids Res. 2018 Jan 4;46(D1):D911-D917. doi: 10.1093/nar/gkx899.
63 A protein-coated magnetic beads as a tool for the rapid drug-protein binding study. J Pharm Biomed Anal. 2010 Jul 8;52(3):420-4. doi: 10.1016/j.jpba.2009.06.023. Epub 2009 Jun 18.
64 The three recombinant domains of human serum albumin. Structural characterization and ligand binding properties. J Biol Chem. 1999 Oct 8;274(41):29303-10. doi: 10.1074/jbc.274.41.29303.
65 Exploring binding properties of sertraline with human serum albumin: Combination of spectroscopic and molecular modeling studies. Chem Biol Interact. 2015 Dec 5;242:235-46. doi: 10.1016/j.cbi.2015.10.006. Epub 2015 Oct 22.
66 Low-expressional IGF1 mediated methimazole-induced liver developmental toxicity in fetal mice. Toxicology. 2018 Sep 1;408:70-79. doi: 10.1016/j.tox.2018.07.004. Epub 2018 Jul 7.
67 Use of peak decay analysis and affinity microcolumns containing silica monoliths for rapid determination of drug-protein dissociation rates. J Chromatogr A. 2011 Apr 15;1218(15):2072-8. doi: 10.1016/j.chroma.2010.09.070. Epub 2010 Oct 16.
68 [Colchicine in chronic liver disease of alcoholic etiology. Double-blind, randomized study of its effects on blood levels of plasma proteins and clinical course in patients]. Rev Assoc Med Bras (1992). 1995 May-Jun;41(3):207-12.
69 Editor's Highlight: Modeling Compound-Induced Fibrogenesis In Vitro Using Three-Dimensional Bioprinted Human Liver Tissues. Toxicol Sci. 2016 Dec;154(2):354-367. doi: 10.1093/toxsci/kfw169. Epub 2016 Sep 7.
70 Covalent binding of the flavonoid quercetin to human serum albumin. J Agric Food Chem. 2005 May 18;53(10):4194-7. doi: 10.1021/jf050061m.